DEA Rescheduling Update: Cannabis Process Stalled Amid Political Crosscurrents and Safety Debates
WASHINGTON D.C. – The highly anticipated process to potentially reclassify cannabis from a Schedule I to a Schedule III controlled substance remains in a state of flux, with the Drug Enforcement Administration (DEA) confirming that key appeal processes are still pending. This development comes as a flurry of commentary and action from political figures, industry…

